Yapan Bio

We provide services to develop and manufacture high-quality Vaccines and Biologics/Bio-therapeutic, to support global biotechnology and biopharma companies, meeting customer satisfaction in compliance with Quality, Regulatory and GMP expectations. Yapan Bio is a Contract Development and Manufacturing Organization (CDMO) serving the needs of the biotechnology industry, globally. Yapan Bio provides robust process development, appropriate scale-up and compliant GMP manufacturing of Vaccines and Biologics/Bio-therapeutics for human clinical studies across the world. Yapan Bio has established state-of-the-art Process Development and GMP facilities for vaccines and biologics, including higher Bio-Safety levels (up to BSL-2+). To provide customized high-quality integrated services to our partners. Yapan Bio was founded by two industry veterans, Atin Tomar and Nirav Desai, with a proven leadership track record in both technical and leadership roles in the biotechnology industry, globally. Yapan Bio’s focus and expertise is in the development and manufacturing of next generation and highly complex molecules/products (recombinant vaccines, viral and non-viral vector-based products, Gene Therapy, monoclonal antibodies etc.). Optimization and scale-up for high product titer, stability and consistent manufacturing output.